CSIMarket
 


Opiant Pharmaceuticals Inc   (OPNT)
Other Ticker:  
 


Opiant Pharmaceuticals Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Opiant Pharmaceuticals Inc's ROI in the third quarter of 2022?
Opiant Pharmaceuticals Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -81.32%.

Within the Healthcare sector 773 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 4316 to 4654.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Investment Change -46.73 % 20.56 % 15.53 % -13.57 % -
Y / Y Net Income Change - - - - 371.34 %
Investment (TTM) in Millions 33 44 39 47 62
Return On Investment (TTM) -81.32 % -41.25 % -13.76 % 6.73 % 3.38 %
OPNT's Overall Ranking # 4654 # 4316 # 3848 # 2091 # 2280
Seq. Investment Change -25.11 % 11.63 % -16.18 % -24 % 69.51 %
Seq. Net Income Change - - - -77.98 % 102.96 %
Net Income (TTM) in Millions -33 -20 -6 3 2




Return On Investment OPNT's Ranking
Within: No.
Industry # 349
Sector # 774
Overall # 4654

Return On Investment Statistics
High Average Low
44.81 %
-28.13 %
-133.05 %
(Dec 31 2019)   (Dec 31 2018)







Financial Statements
Opiant Pharmaceuticals Inc's III. Quarter Investments $ 33 Millions OPNT's Balance sheet
Opiant Pharmaceuticals Inc's III. Quarter Income $ -10 Millions Quarterly OPNT's Income Statement
OPNT's Income by Division See OPNT's Income by Division


OPNT Annual Return On Investment (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Investments in Millions 47 54 35 20 15
Y / Y Investment Growth -13.57 % 56.31 % 77.26 % 29.39 % -
Net Income in Millions 3 -2 12 -21 7
Y / Y Net Income Growth - - - - -
Annual Return On Investment 6.42 % -3.43 % 33.44 % -108.36 % 43.53 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 6.42 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OPNT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for OPNT's Competitors
Roi for Opiant Pharmaceuticals Inc's Suppliers
Return On Investment for OPNT's Customers

Other Ratios
OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Statistics
OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI


Date modified: 2022-11-16T06:30:24+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com